Thales Alenia Space, a joint-venture between Thales (67%) and Leonardo (33%), harness students’ curiosity for space, science and life on Mars with the launch of MARSBalloon 2024.
Led by Thales Alenia Space graduates and apprentices in the UK, MARSBalloon is a hands-on science project for primary and secondary students and shows how exciting and varied career opportunities in space, engineering and science can be – without putting on a space suit.
Students work together to create experiments to test the response of electronics, materials, plants and even food to the harsh conditions in space.
Experiments fit inside a small capsule and fly on the high altitude balloon, rising to an altitude of 30km, more than twice the height of commercial airliners where conditions are very similar to the surface of Mars – including temperatures of -50°C and pressures 1/100th that of sea level.
This year’s MARSBalloon will also have a competitive element, with prizes awarded for primary and secondary categories for Best Innovation, Best Decoration, Engineers Choice and VIP Judge’s Choice award.
The deadline for registration is 8th March 2024 with the launch of the balloon in May.
8th March: Last day for Registration. The process take five minutes and can be done here.
30th April: Deadline for experiment delivery to Thales Alenia Space
May / June: MARSBalloon launch (depending on weather conditions)
Ballymacash Primary school has already signed up. Primary teacher, Susan Brown, said: “We are so excited to be involved in such an amazing activity. The students can’t wait to start dreaming up their own experiments.
“We’re looking forward to having our very own MARSBalloon workshop in March – so watch this space to see what the children come up with!”
Drashti Shah, Thales Alenia Space Engineer and MARSBalloon Project Manager, said: “We are delighted to have launched MARSBalloon 2024. We had a record number of participants last year, flying over 200 experiments into the stratosphere, and this year we have changed the dates to allow more schools to get involved. I
“t is a fantastic fun, free of charge that really gives young student experience of deigning their own experiments and first-hand experience learning more about space, widening their future career horizons”
Drawing on over 40 years of experience and a unique combination of skills, expertise and cultures, Thales Alenia Space delivers cost-effective solutions for telecommunications, navigation, Earth observation, environmental management, exploration, science and orbital infrastructures.
Governments and private industry alike count on Thales Alenia Space to design satellite-based systems that provide anytime, anywhere connections and positioning, monitor our planet, enhance management of its resources, and explore our Solar System and beyond. Thales Alenia Space sees space as a new horizon, helping to build a better, more sustainable life on Earth.
A joint venture between Thales (67%) and Leonardo (33%), Thales Alenia Space also teams up with Telespazio to form the parent companies’ Space Alliance, which offers a complete range of services. Thales Alenia Space posted consolidated revenues of approximately 2.2 billion euros in 2022 and has around 8,500 employees in 10 countries with 17 sites in Europe and a plant in the US.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Countless lives could be saved thanks to a multi-million pound UK government investment in potential breakthrough medical devices.
As part of a £10 million funding package for boosting access to medical technology, eight innovative tech companies will be supported to bring their devices to market. It could help transform the way we treat some of the biggest causes of death and disability in the UK.
One device, by HistoSonics, aims to identify and destroy liver cancer tumours using focused ultrasound waves. These waves break down tumours without damaging healthy tissue, offering a safer alternative to radiotherapy and other high intensity treatments. It could improve quality of life for many patients going through treatment – reducing hospital visits, post procedure complications, and making pain management easier.
Today’s announcement is part of the government’s long-term plan to ensure the NHS and its patients can get quicker access to new ‘groundbreaking’ technologies. It follows the unveiling of our groundbreaking blueprint for boosting NHS medtech and turning innovation into real benefits for society last year.
Health Minister Andrew Stephenson said: “NHS staff need access to the latest technology to deliver the highest quality care for patients and cut waiting lists – one of our top five priorities.
“These cutting-edge technologies could help thousands of patients with a range of conditions, including cancer, stroke, and Alzheimer’s, while easing pressure on our hospitals and reducing healthcare inequalities.
“Our investment in these pioneering companies is part of our long-term plan for a faster, simpler and fairer health care system, and demonstrates our clear commitment to ensuring the UK is the most innovative economy in the world.”
One company is developing a blood test for Alzheimer’s Disease which means patients could be identified and treated earlier. Roche Diagnostics Ltd has developed the Amyloid Plasma Panel – a blood test which could help clinicians decide if patients with cognitive impairment should undergo tests or imaging to confirm Alzheimer’s Disease.
A portable blood test, from Upfront Diagnostics, could help paramedics identify stroke patients more quickly. Currently, ambulance workers can’t recognise a patient with a blood clot blocking the flow of blood and oxygen to their brain, who would require urgent treatment at stroke centres rather than local hospitals.
The blood test could help them recognise these cases on the spot – so patients could be taken to a comprehensive stroke centre for immediate, vital treatment. It could mean thousands are spared long-term disability and the associated care costs, while reducing pressure on A&E departments nationwide.
Dr Marc Bailey, Medicines and Healthcare products Regulatory Agency Chief Science and Innovation Officer, said: “We are very excited to announce the final eight selected technologies in the new IDAP pilot scheme.
“This is designed to explore how support from the regulator, UK health technology organisations and NHS bodies can accelerate the development of transformative medical devices from their initial proof of concept through to uptake in the NHS.
“The pilot criteria prioritises patient need in all aspects of decision-making and, by supporting innovative medical technologies, will ease pressure on the healthcare system. Most important, it’s an initiative which could be life-changing for many patients.
“We are committed to being a regulator that establishes the UK as a centre of medical innovation and look forward to working with the wider healthcare system to achieve this.”
The funding is part of a radical new programme called The Innovative Devices Access Pathway (IDAP), which aims to bring state-of-the-art technologies and solutions to the forefront of the NHS. Currently in the pilot stage, the funding will be used to test the new technologies for use on a large scale as quickly as possible.
The government is investing £10 million in the pilot as part of a wider programme of work to accelerate access to medical technology.
The programme is run by the Medicines and Healthcare products Regulatory Agency (MHRA), The National Institute for Health and Care Excellence (NICE), NHS England, Health Technology Wales, and Scottish Health Technology Group. They will be providing tailored, intensive advice on regulatory approval, health tech assessments and access to the NHS.
Jeanette Kusel, Director of NICE Advice (The National Institute for Health and Care Excellence) said: “NICE’s ambition is to drive innovation into the hands of health and care professionals to enable best practice in health and care treatment.
“Through IDAP and our support service NICE Advice, we aim to be a trusted adviser, providing tailored advice and supporting businesses along the whole product lifecycle helping them realise their ambition and helping bring the very best of innovation into the NHS and the hands of patients.”
Lenus Health Ltd. is using artificial intelligence to predict patients at risk of hospitalisation for Chronic Obstructive Pulmonary Disease, which causes the airways to become narrow and damaged, resulting in breathing difficulties.
The company collects data from wearable devices, sensors and apps and uses AI to predict which patients are at greater risk of hospital admissions. This allows them to be monitored and treated more effectively, while simultaneously reducing pressure on hospitals.
Another device aims to reduce inequalities in the field of lung health. Oximeters – devices clipped over the end of a fingertip – are used widely at hospitals and at home to assess how well the lungs and circulatory system are working. However, research suggests this technology may not accurately detect falling oxygen levels in people with darker skin tones.
EarSwitch has produced a device which detects oxygen levels from the inner ear-canal instead, which is not pigmented irrespective of the person’s skin colour. It could offer better quality readings and a more innovative approach to oxygen level monitoring.
Vin Diwakar, Interim National Director of Transformation, NHS England, said: “This is an important milestone in our work to ensure the NHS continues to get the best new technologies and treatments to patients faster, having already rolled out more than 100 new treatments through the cancer drug fund and setting up a dedicated programme to prepare for new Alzheimer’s treatments once they are approved.
“We will be working closely with our partners to support those companies selected for the pilot so that more game-changing, life-saving technologies are introduced quickly and safely on the NHS.”
Other technologies set to benefit from a share of the funding include:
Multiple Sclerosis fatigue app: Avegen Ltd. has developed a new smartphone app that delivers exercises, cognitive behaviour therapy and targeted physical activity in a personally customisable format to help patients manage Multiple Sclerosis (MS).
Self-test for neutropenia: 52 North Health. has developed a new device to allow chemotherapy patients to self-test at home – using a finger-prick blood test – for neutropenic sepsis. This is a life-threatening condition in patients whose immune system is suppressed.
Algorithm infection predictor: Systemic Inflammatory Response Syndrome (SIRS) is a life-threatening medical condition caused by the body’s overwhelming response to infection or inflammation. Presymptom Health Ltd. has developed a new test and algorithm with the potential to predict infection status up to three days before conventional diagnosis is possible.
Dr Susan Myles, Director of Health Technology Wales, said: “Health Technology Wales is proud to have played a role in the selection of eight pilot IDAP technologies which have the potential to support clinicians and improve the lives of patients across the UK.
“We look forward to continuing to support the adoption of innovative health technologies by the NHS.”
In a major report today Westminster’s Science, Innovation & Technology Committee calls for steps to develop the potential of bacteria-killing viruses – called bacteriophages or phages for short – that can provide an alternative to antibiotics that are attracting growing resistance.
Phages have been used as therapy for over a hundred years, but interest has increased in recent years as the widespread use of antibiotics is leading to alarming antimicrobial resistance (AMR) to even the most effective treatments. But they have never been licensed for therapeutic use in the UK. They have only been used as “compassionate” treatments of last resort in isolated cases of otherwise intractable infections.
One of the problems has been an impasse: in order to be deployed in clinical trials phages must be manufactured to the Good Manufacturing Practices (GMP) standard – but investment in compliant manufacturing plants will only be justified following successful clinical trials.
Rt Hon Greg Clark MP, Chair of the Committee, said: “Phages offer a possible response to the increasing worldwide concerns about antimicrobial resistance.
“But the development of phage therapies is at an impasse, in which clinical trials need new advanced manufacturing plants, but investment requires clinical trails to have demonstrated efficacy.
“The Committee is asking the Government to consider whether the mothballed Rosalind Franklin Laboratory in the West Midlands could provide a suitable facility.
“The Laboratory, which has already received over £1 billion of public funding, was established by the Government to bring to an end the inadequacy of testing capacity that so hampered the national response to Covid.
“It consists of modern, secure laboratory facilities and was meant to be an important source of national resilience against future pandemics. But the Rosalind Franklin Laboratory has suddenly appeared for sale on the property website Rightmove, to the astonishment of the science and health communities.
“Our Committee’s report on phages asks for the Rosalind Franklin Laboratory to be considered for this purpose, rather than be lost to the nation and to science in a firesale.”
The Committee recommends that the Government should consider establishing a small GMP facility on the lines of the Catapult network which provides shared facilities for companies who cannot afford to make the level of investment on their own.
The Committee also calls on the Medicines and Healthcare Products Regulatory Agency (MHRA), Department for Health and Social Care (DHSC), and phage researchers to work together to make for a more promising route for phage research to be funded and its products licensed for use.
The Committee calls for:
Awareness-raising for healthcare students and professionals of the antimicrobial potential of phages where antibiotics have failed or are failing
Government and its agencies to make a definitive and positive statement on the role of phages in the national approach to anti-microbial resistance (AMR), which is important in research funding decisions and for private investment in commercial phages
The MHRA to consider allowing the compassionate use of non-GMP phages produced in the UK for last resort medical cases where other medical approaches have failed or are failing
The MHRA to review how current regulations would govern liability for clinicians and hospitals who used UK non-GMP phages,
Healing the Rift: UK to associate to Horizon Europe and Copernicus programmes in new agreement with the EU
UK to associate to Horizon Europe and Copernicus programmes through a bespoke new agreement with the EU.
Prime Minister secured improved financial terms of association that are right for the UK and protect the taxpayer.
British scientists encouraged to apply now for grants and projects with certainty.
UK confirms it will take forward its own fusion energy strategy instead of associating with the Euratom programme.
UK scientists will have access to the world’s largest research collaboration programme, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation.
From today (Thursday 7 September), UK researchers can apply for grants and bid to take part in projects under the Horizon programme, with certainty that the UK will be participating as a fully associated member for the remaining life of the programme to 2027.
Once adopted, the UK will also be able to join the governance of EU programmes – which the UK has been excluded from over the last three years – ensuring we can shape collaboration taking place next year. And UK researchers will be able to lead consortia in the next work programme of Horizon Europe projects.
Horizon will give UK companies and research institutions unrivalled opportunities to lead global work to develop new technologies and research projects, in areas from health to AI. This will not only open up cooperation with the EU, but also Norway, New Zealand and Israel which are part of the programme – and countries like Korea and Canada which are looking to join too.
This follows a call between the UK Prime Minister Rishi Sunak and EU Commission President Ursula Von der Leyen yesterday (6 September). They are encouraging UK scientists to apply with confidence from today and they agreed that the UK and EU will work together to boost participation.
As part of the new deal negotiated over the last six months, the Prime Minister has secured improved financial terms of association to Horizon Europe that are right for the UK – increasing the benefits to UK scientists, value for money for the UK taxpayer, and mitigating the impact that the EU’s delays to our association will have on participation rates of researchers.
The UK will also associate to Copernicus, the European Earth Observation programme. This will provide the UK’s earth observation sector with access to unique data – valuable to helping with early flood and fire warnings, for example – and with the ability to bid for contracts, which they haven’t been able to access for three years.
In line with the preferences of the UK fusion sector, the UK has decided to pursue a domestic fusion energy strategy instead of associating to the EU’s Euratom programme. This will involve close international collaboration, including with European partners, and a new, cutting-edge alternative programme, backed by up to £650m to 2027. It will ensure UK taxpayer funding is spent in the UK’s best interests.
Together, this deal is set to create and support thousands of new jobs as part of the next generation of research talent. It will help deliver the Prime Minister’s ambition to grow the economy and cement the UK as a science and technology superpower by 2030.
UK Prime Minister Rishi Sunak said: Innovation has long been the foundation for prosperity in the UK, from the breakthroughs improving healthcare to the technological advances growing our economy.
“With a wealth of expertise and experience to bring to the global stage, we have delivered a deal that enables UK scientists to confidently take part in the world’s largest research collaboration programme – Horizon Europe.
“We have worked with our EU partners to make sure that this is right deal for the UK, unlocking unparalleled research opportunities, and also the right deal for British taxpayers.”
New financial protections for the British taxpayer, especially in the first years of association when UK scientists’ participation will be recovering, ensures:
UK taxpayers will not pay for the time where UK researchers have been excluded from since 2021, with costs starting from January 2024 – delivering much better terms for 2023. This will also provide breathing space to boost the participation of UK researchers in open calls for grants before we start paying into the programme.
The UK will have a new automatic clawback that protects the UK as participation recovers from the effects of the last two and a half years. It means the UK will be compensated should UK scientists receive significantly less money than the UK puts into the programme. This wasn’t the case under the original terms of association.
Secretary of State for Science, Innovation and Technology Michelle Donelan said: “Today is a fantastic day for UK science and our whole economy. We have listened to the sector, and through hard work and negotiation we have secured an excellent deal for researchers, taxpayers and businesses.
“The Horizon programme is unrivalled in its scope and opens up a world of opportunity for cooperation on science that delivers real-world benefits for the UK – creating jobs, boosting our economy and opening up collaboration for the sector with some of our closest partners, whether on tackling climate change or advancing cancer research.
“This deal is a crucial step forward on our mission to become a science and tech superpower by 2030.”
Health and Social Care Committee Chair, Steve Brine MP said: “The announcement that the UK will rejoin the flagship Horizon research programme is of huge importance to the future of cancer research.
“Too much time and work has been lost leaving many in the health and scientific communities angry. They must be profoundly relieved having warned that without access to Horizon, the UK risked losing not only its world-leading reputation on science but access to research upon which crucial work depends.
“Next week we’ll be speaking to renowned specialists in cancer research and questioning them on what impact this major development is likely to have for their work as they seek to revolutionise the diagnosis and treatment of future cancer.”
President of UUK, Professor Dame Sally Mapstone: “The entire research community, within our universities and beyond, will be delighted at the news that an agreement has been reached.Overcoming the obstacles to association was no small feat and we are grateful to the government and the commission for their perseverance to secure this successful outcome.
“Horizon Europe has been the basis of scientific collaboration for over 30 years. From early detection of ovarian cancer to developing clean energy networks involving dozens of universities and many industrial partners, Horizon lets us do things that would not be possible without that scale of collaboration.
“Allowing our scientists to work together, irrespective of borders, is in all of our interests. Our universities will now do everything possible to ensure the UK rapidly bounces back towards previous levels of participation and is able to secure genuine value, delivering the wealth of research opportunities available.”
The Academy of Medical Sciences, the British Academy, the Royal Academy of Engineering, and the Royal Society have issued a joint statement on the UK’s association to Horizon Europe:
‘This is a great day for researchers in the UK and across Europe. The Horizon programme is a beacon of international collaboration and UK-based academic and industrial researchers will now be back at the heart of that.
‘Research is vital to tackling the key problems we face, from global challenges such as climate change to driving productivity growth and creating new jobs locally. Our involvement in Horizon Europe will make the UK stronger and is a big win for global research and innovation.‘
Michelle Mitchell, Chief Executive of Cancer Research UK, said: “Horizon Europe association is overwhelmingly in the best interests of cancer patients and scientists, and it is great news for cancer research that agreement has finally been reached between the UK and EU.
“There will be relief throughout the research community that the uncertainty of the last two and a half years has come to an end. Nearly three quarters of respondents to our survey of cancer researchers cited funding from the EU as important for their work, showing how crucial Horizon Europe association is for the future of cancer research.
“We hope that this deal paves the way for the UK’s ongoing participation in future European research programmes. It is essential that the European Commission, the UK Government and UK research funders work with urgency to rebuild the strong position the UK occupied in the Horizon programme, and get funds and global collaboration flowing again into our research institutions.”
Dame Professor Angela McLean, Government Chief Scientific Adviser said: “This is great news for UK science and technology.
“International collaboration is a vital part of a thriving science ecosystem and association with the Horizon programme bolsters our plans to secure our status as a science and technology superpower.
Chief Executive of the Russell Group, Dr Tim Bradshaw said: “Association to Horizon Europe is tremendous news for UK science, research and innovation.
“We are delighted that a good deal has been struck, so all credit to the negotiating teams who have been working hard behind the scenes to get this over the line.
“This deal is a true win-win for everyone. The scale of research supported by Horizon Europe will help deliver medical breakthroughs, new technologies, and advances in areas such as AI to improve all our lives and help tackle the shared environmental, economic, and social challenges we face.
“The research community on both sides of the Channel are raring to go and will spare no effort in making our association a success. Universities have plans in place to get researchers to apply and our partner universities and businesses across the EU – and in other associated countries – are eager to work with our institutions.
“We will be ready to work with Government and the Commission to make the most of Horizon’s opportunities from day one and beyond into its successor.”
John Hanley, Chair of the UKspace trade body, said: “UKspace welcomes the news that the UK is reassociating with the EU Copernicus and Horizon Programmes.
“We have a strong track record within Copernicus with UK industry securing valuable contracts that have delivered jobs and growth across the country whilst unlocking a better understanding of our planet.
“We look forward to working with the Government to capitalise quickly on this agreement and identify the actions needed to build upon the UK’s national Earth Observation initiatives to ensure that industry can once more take a leading role in the largest multi-lateral EO Programme in the world.”
Grazia Vittadini, Chief Technology Officer for Rolls-Royce, said: “Horizon Europe has had a significant impact on Aerospace technologies and in helping Rolls-Royce remain at the forefront of technological advancement.
“We greatly welcome the UK’s return to the Horizon Europe programme, and look forward to going further and doing more, leveraging public-private partnership to continue driving world-leading innovation and competitiveness.
Dr Diana Beech, Chief Executive Officer, London Higher said: “The confirmation that the UK will rejoin Horizon Europe is welcome news for universities across London, the UK’s top ranked innovation cluster.
“The wait to associate to Horizon may have been lengthy but worthwhile, as today’s announcement shores up the future of research, innovation and higher education across the United Kingdom.
“With the assurance of association, London’s higher education and research community now has a renewed sense of purpose and optimism that London can reach its true potential as a research powerhouse.
“Association is both a recognition of the value we bring to the international scientific community and the acknowledgment that we are still very much a part of a global network of knowledge-sharing and innovation.
“Our universities now have the certainty and stability needed to continue powering the engine of UK innovation and to build connectivity across the regions as we seek to level up across the country and make the UK a global science superpower.
“We are committed to working collaboratively with our European partners, leveraging our collective expertise to drive innovation, support research excellence, and build a brighter future for all.”
Professor Paul Stewart FMedSci, Academy of Medical Sciences Vice President, Clinical, said: “Today marks a pivotal moment for UK science. After a hiatus, the scientific community is celebrating the tremendous news that we are once more part of the EU’s flagship funding programme.
“By associating to Horizon Europe, we now have the commitment and momentum to drive forward the Government’s vision for an innovative, high growth future and are well placed to support the diverse and highly skilled research talent that underpins our life sciences sector.
“Health research is an international endeavour, it relies on supporting the best ideas, but also on creating cross-border networks which is good news for the UK, Europe and the rest of the world. Association sends a very strong message that the UK is open for business and remains a prime destination to work on health research and innovation to improve lives.”
UKRI Chief Executive Professor Dame Ottoline Leyser said: “Today’s agreement on UK association to Horizon Europe is brilliant news.
“The UK has a long track record of mutually beneficial participation in previous EU schemes and this decision enables us to build on those highly successful collaborations to maximise the opportunities membership of Horizon Europe provides.
“UKRI is looking forward to working with our communities and partners to capture the many benefits of Horizon Europe for researchers and businesses.”
John Harrison, Chairman of Airbus UK: “It is great news that the U.K. will be rejoining Horizon Europe, which is a key funding programme for research and innovation, as well as the Copernicus programme.
“Having provided many of Copernicus’ critical technologies from the U.K., as well as designing and building the Sentinel 5P satellite in Stevenage, we look forward to contributing to future Copernicus Earth observation missions which play such a key role in understanding and tackling the planet’s changing climate.”
Dr Paul Bate, Chief Executive of the UK Space Agency, said: “The UK has a long history of expertise and innovation in Earth observation, so it is excellent news that we are going to continue our association in the EU part of Copernicus programme. This is a great outcome for our world-leading Earth observation sector, who we have worked closely with to support.
“Participating in Copernicus will enable the UK space sector to continue to play a significant role in the development of critical missions that will enable us to monitor our planet more effectively and lead a global effort through the use of satellite data to find new solutions to the urgent challenge of climate change.”
Ilan Gur, CEO of Advanced Research + Invention Agency: “A strong, interconnected scientific ecosystem is the foundation of breakthrough discovery and invention.
“This is wonderful news — a boost to science innovation not just for the UK but for the world!
A European mission to explore how gravity, dark energy and dark matter has shaped the Universe has launched following £37 million UK Space Agency funding.
The Euclid space telescope will map the “dark Universe” by observing billions of galaxies out to 10 billion lightyears, across more than a third of the sky, to gather data on how its structure has formed over its cosmic history.
Led by the European Space Agency (ESA) and a consortium of 2,000 scientists across 16 countries, Euclid will spend six years venturing through space with two scientific instruments: a UK-built visible imager (VIS) that will become one of the largest cameras ever sent into space, and a near infrared spectrometer and photometer, developed in France.
Secretary of State for Science and Technology Chloe Smith said: “The launch of the Euclid mission is a truly significant moment. Backed by £37 million in UK funding and supported by our remarkable scientific talent and expertise, the mission will launch one of the largest cameras ever into space to look out across our universe.
“The mission will gain unparalleled insight into the mysteries of how the Universe was formed, delivering ground-breaking discoveries that will redefine what we know about space.”
Dr Paul Bate, Chief Executive of the UK Space Agency, said: “Watching the launch of Euclid, I feel inspired by the years of hard work from thousands of people that go into space science missions, and the fundamental importance of discovery – how we set out to understand and explore the Universe.
“The UK Space Agency’s £37 million investment in Euclid has supported world-class science on this journey, from the development of the ground segment to the build of the crucial visible imager instrument, which will help humanity begin to uncover the mysteries of dark matter and dark energy.”
The Euclid spacecraft being loaded into the SpaceX Falcon 9 fairing ahead of launch, on 27 June 2023. Credit: SpaceX.
Euclid took off on board a SpaceX spacecraft from Cape Canaveral in Florida at 4.12pm (BST) on 1 July.
The UK Space Agency’s funding goes back to 2010, up to 2024, and is divided between teams at University College London, The Open University, University of Cambridge, University of Edinburgh, University of Oxford, University of Portsmouth and Durham University.
All these institutions have contributed to the development and implementation of the Euclid UK Science Ground Segment (UKSGS), which runs the Euclid data analysis. Led by the University of Edinburgh, which hosts Euclid’s UK Science Data Centre (SDC-UK), the UKSGS will process hundreds of petabytes of data over the next six years to produce maps of the galaxies and dark matter of the Universe.
The wider Euclid Consortium includes experts from 300 organisations across 13 European countries, the US, Canada and Japan.
The Science and Technology Facilities Council (STFC) also contributed to design and development work on Euclid instrumentation and provided funding to UK astronomy teams who will analyse the data returned from the mission, including studies on the physics responsible for the observed accelerated expansion of the Universe.
Executive Chair at STFC Professor Mark Thomson said: “Euclid will answer some of the biggest and most profound questions we have about the Universe and dark energy. Congratulations to everyone involved in the design, construction and launch of Euclid – we are opening a new window on the cosmos.
“This is a fantastic example of close collaboration between scientists, engineers, technicians, and astronomers across Europe working together to tackle some of the biggest questions in science.”
Research funded by the UK Space Agency
University College London (MSSL and P&A) – Design, build and testing of Euclid’s VIS optical camera (£20.5 million)
UCL researchers have led on designing, building and testing the VIS optical camera, one of Euclid’s two instruments, working with teams at Open University as well as in France, Italy and Switzerland.
The core electronics for the instrument, including its complex array of 36 CCDs (that convert photons into electrons), were built at UCL’s Mullard Space Science Laboratory.
The camera, one of the largest ever sent into space, will take high resolution, panoramic images of a large swathe of the Universe, going back 10 billion years and covering a third of the night sky.
Professor Benjamin Joachimi (UCL Physics & Astronomy) is also playing a key role in the ground-based part of the mission (the ground segment), converting Euclid’s raw data into statistical summaries that can be compared to our current theoretical models of the universe.
Professor Mark Cropper, leader of the VIS camera team at UCL Mullard Space Science Laboratory, said: “The VIS instrument will image a large swathe of the distant Universe with almost the fine resolution of the Hubble Space Telescope, observing more of the Universe in one day than Hubble did in 25 years.
“The data will allow us to infer the distribution of dark matter across the Universe more precisely than ever before. The galaxies being imaged are up to 10 billion years old so we will also see how dark matter has evolved over most of the Universe’s history. The Universe on this scale has not yet been seen in this level of detail.”
Professor Tom Kitching, one of four science co-ordinators for Euclid, said: “The puzzles we hope to address are fundamental. Are our models of the Universe correct?
“What is dark energy? Is it vacuum energy – the energy of virtual particles popping in and out of existence in empty space? Is it a new particle field that we didn’t expect? Or it may be Einstein’s theory of gravity that is wrong.
“Whatever the answer, a revolution in physics is almost guaranteed.”
University of Edinburgh (£8.9 million)
Edinburgh has been involved in the design and build of Euclid from its earliest days – leading the Euclid gravitational lensing data analysis, the UK Data Science Analysis and host to the UK’s Euclid Science Data Centre which will process hundreds of petabytes of data throughout the mission.
Professor Andy Taylor, leader of the gravitational lensing analysis for Euclid, the UK’s Euclid Science Data Analysis and SDC-UK, said: “This is a very exciting time for astronomy, and cosmology in particular.
“Euclid is designed to answer some of the biggest questions we have about the Universe. It has been a lot of hard work by many scientists to get here, but the results could change how we understand nature.
Professor Alkistis Pourtsidou, leader of Euclid’s nonlinear modelling team said: “Euclid is going to provide a very large and very detailed 3D map of the Universe, across the sky and along time.
“This map is a remarkable achievement combining state-of-the-art science and engineering. We want to extract the maximum amount of information from it and use it to figure out how nature works at the most fundamental level.
Dr Alex Hall, deputy leader of the gravitational lensing science working group, said: With the launch of Euclid begins an astronomical observing campaign that is amongst the most ambitious ever attempted.
“By imaging over a billion galaxies, Euclid will allow us to make a map of dark matter with unprecedented precision that will answer fundamental questions about our Universe. The next few years are going to be very exciting, and it is a privilege to be part of this incredible project.”
University of Oxford – Developing lensing signal measurement and correction for the effects of telescope and detectors on the data (£2.1 million)
Oxford’s Department of Physics has played a significant role in the lensing data analysis. As well as contributing to the development of the method used to measure the lensing signal, the team have specialised in correcting for the effects that the telescope and imaging detectors have on the data.
No telescope system is perfect – there is always some blurring and distortion of the images – and Oxford’s role has been not only to build the software models but also to devise ways of calibrating those models using dedicated in-orbit data from Euclid. These are crucial steps that allow the lensing measurements to be used to explore the dark side of our Universe.
Professor Lance Miller, leader of the work at the University of Oxford, said: “This is an incredibly exciting time.
“This space mission is the result of years of work and for us here in Oxford, that work continues as we put the finishing touches to the software that will be analysing some of the first Euclid data sent back to Earth, from August onwards.
“I have been working on Euclid since its inception, so to have reached this major milestone today is extraordinary. It is fantastic to be part of a mission that could play a fundamental role in our understanding of the Universe.
University of Portsmouth – Writing code for data analysis (£1.8 million)
The University of Portsmouth’s team, led by Ernest Rutherford Fellow, Dr Seshadri Nadathur, has been working with the wider European team, writing code that will help analyse data from the spacecraft.
Dr Seshadri Nadathur, from Portsmouth’s Institute of Cosmology and Gravitation, said: “Galaxies are not randomly scattered around the sky – instead there are patterns in their positions that are relics of correlations created at the time of the Big Bang, shaped over billions of years by the interplay of gravity pulling galaxies together and the expansion of the Universe driving them apart.
“By measuring and understanding these patterns in the maps Euclid will provide, we will learn about the mysterious force of dark energy that seems to be driving the Universe to expand ever faster.
“The team at Portsmouth has been busy developing and testing software that builds the maps and allows them to correct for any spurious patterns in the galaxy positions that arise purely due to variations in the performance of the telescope and instruments, so that we can isolate the true cosmological patterns we are interested in.”
Durham University – Building Euclid tolerance to radiation and supercomputer mock data (£1.3 million)
Professor Richard Massey, of Durham University’s Centre for Extragalactic Astronomy/Institute for Computational Cosmology, is a founder of the Euclid mission and has been developing its design and science goals for 20 years.
Work from a team of international researchers has included making Euclid’s camera more tolerant to the high radiation environment in which it will need to survive above the Earth’s atmosphere, learning from our experience with the Hubble Space Telescope.
As well as leading on Euclid’s radiation monitoring and mitigation strategy, Durham has used supercomputer simulation capabilities to create mock data to train Euclid’s analysis software, which will be compared against the spacecraft’s real observations.
Professor Richard Massey said: “When exploring any wild new frontier, the first step is to map the land. Euclid will make the largest ever map (with a tiny ‘you are here’ at the centre) and will show the invisible Universe.
“By revealing where dark matter and dark energy hide, we hope to take the second step – to discover what they are and trigger a gold rush of new science about how they behave.
“Euclid is like the Hubble Space Telescope, but with a wide-angle view. It will let astronomers stand back and see the sweeping vista of the Universe – but with the same high-resolution detail.
“Exploring and mapping new frontiers is the most human thing possible. Helping shape our next look into the dark has been a privilege.
“It has taken 20 years to make Euclid’s technology possible, engineer its details, and navigate the politics of competing against other proposed missions that would all discover amazing things. That rocket carries the sense of exploration and lifetimes’ work of thousands of scientists and engineers.”
The Open University – Developing and testing VIS detectors (£1.2 million)
The Open University’s Centre for Electronic Imaging (CEI) has been involved in developing the detectors for the VIS instrument and testing how they will perform in the harsh radiation environment in space.
The team will continue to monitor the detectors during the mission, to help mitigate the effects of the damage caused by high energy particles outside the Earth’s protective atmosphere, allowing Euclid to return the best possible science for the mission lifetime.
Dr Jesper Skottfelt, CEI Fellow at The Open University, said: “After 15 years of CEI involvement in the Euclid mission, it is exciting to see the spacecraft being launched.
“Our study of the VIS detectors has led to the development of new techniques to correct the effects of radiation damage which will enhance science return for this and future space missions.
“We look forward to seeing the progress Euclid will deliver towards answering some of the most fundamental questions we have about our Universe.
University of Cambridge – Developing astrometric calibration pipeline for Euclid image data (£870,000)
The University of Cambridge’s Institute of Astronomy (IoA) team has been involved in Euclid since 2010, supporting development of the astrometric calibration pipeline for the optical image data from Euclid, ensuring that the positions of the billions of sources to be imaged by Euclid can be determined to exquisite accuracy.
Nicholas Walton, leader of the IoA Euclid team and a Director of Research at the University of Cambridge, said: Dark energy and dark matter fundamentally govern the formation and evolution of our Universe.
“The Euclid mission will finally uncover the mysteries of how these ‘dark’ forces have shaped the cosmos that we see today, from life here on Earth, to our Sun, our Milky Way, our nearby galaxy neighbours, and the wider Universe beyond.”
MEDICAL RESEARCH SCOTLAND INSPIRES OVER 1,400 YOUNG PEOPLE WITH LIVE-STREAMED EVENTS
Medical Research Scotland, Scotland’s largest independent medical research charity, has helped over 1,400 young people across Scotland connect with the country’s leading scientists and academics to learn about further education and careers in medical science.
The Medical Research Scotland virtual academy has had a significant impact on the education and career prospects of pupils across Scotland. With participation from over 1,400 students from 36 schools spanning from Aberdeen to the Scottish Borders, the academy has successfully engaged students with an interest in STEM subjects. The primary goal for the academy is to address the shortage of STEM skills in Scotland by providing students with interactive experience and exposure to medical research.
S4, S5 & S6 pupils from schools across Scotland joined each Friday morning for a month of live streamed weekly interactive lessons, which were broadcasted straight to their science classrooms, allowing pupils to watch from the comfort of their own learning environments. Throughout the course, students were treated to a range of inspiring and insightful presentations from scientists, lecturers, and PhD students whose studies were funded by Medical Research Scotland.
The academy is a free tool that was delivered virtually and is also available to be streamed on demand making it a versatile resource that can be utilised throughout teaching schedules.
One school that benefitted from the Medical Research Scotland Academy virtual webinar series was James Gillespie’s High School in Edinburgh.
Pupils here gained the opportunity to learn about medical research into viruses, pharmaceuticals, how medical research was an integral part of combatting the global pandemic and much more from previous and present PhD students from the University of St Andrews, University of Aberdeen, Heriot-Watt University and the University of Dundee.
Iain Coltart, Head of Science at James Gillespie’s High School, said: “I am thrilled to see the incredible impact of the Medical Research Scotland Academy on our pupils.
“Through this programme, our students have gained invaluable insights into cutting-edge medical research, engaging with leading experts in the field and deepening their understanding of scientific concepts.
“The learning experience and exposure to real-world medical research has ignited their passion for science. We are grateful for this unique opportunity that has empowered our students and inspired them to pursue careers in the field of medical research.”
Professor Heather Wallace, Chair of Medical Research Scotland, said:“As Chair of Medical Research Scotland, I take pride in Scotland’s rich heritage of producing world-class research scientists who have made ground-breaking discoveries and contributed to global health advancements.
“The goal of the Medical Research Scotland Academy is to inspire and foster connections between the next generation of aspiring medical professionals and valued academics in Scotland. We have witnessed the immense enthusiasm for medical science among school leavers from various schools across the country, and it is truly gratifying to see.”
Medical Research Scotland is dedicated to advancing health in Scotland and beyond through the support of cutting-edge research aimed at enhancing the diagnosis, treatment, and prevention of diseases.
To join us in our mission, please visit our website at:
Foreign Secretary James Cleverly visited Scotland one year on from COP26 in Glasgow. He went to the University of Strathclyde to meet scientists and engineers developing lower cost, recyclable battery tech
UK government funded research aims to improve clean energy access for 25 million of world’s poorest people and save nearly 2.5 million tonnes of carbon emissions
Foreign Secretary also visited the Foreign, Commonwealth & Development Office’s joint HQ in East Kilbride, which employs almost 1,000 staff in Scotland
Foreign Secretary James Cleverly met with scientists and engineers developing revolutionary battery technologies in Glasgow – a year on from world leaders gathering in the city for the COP26 climate summit.
The Foreign, Commonwealth & Development Office (FCDO) is supporting the Faraday Institution and researchers from the University of Strathclyde and the University of St Andrews, through its Transforming Energy Access (TEA) programme to help offer lower cost, more recyclable battery technology to developing countries.
The UK government announced £126 million of new scale-up funding for TEA during Energy Day at COP26 – focused on reducing carbon emissions by 2.5 million tonnes and securing better access to clean energy for 25 million people.
Since TEA was launched in 2015, it has provided 16 million of the world’s poorest people with improved access to clean energy and generated 96,000 green jobs.
The Foreign Secretary also visited the FCDO’s joint HQ at Abercrombie House, in East Kilbride, where almost 1,000 staff are at the heart of shaping and delivering UK foreign policy on issues such as climate change, including through the TEA programme.
Foreign Secretary James Cleverly said: “Today’s visit is hugely important for me, to see first-hand how people in Scotland are building on the legacy of the UK’s COP Presidency in Glasgow to make progress in the fight against climate change.
“Scotland is famous as an innovation superpower. It has given the world the television, telephone and penicillin, so it was wonderful to learn how Scottish scientists are continuing this rich tradition to develop the revolutionary new batteries of the future fuelled by cleaner energy.
“The UK government is proud to support vital work at the universities of Strathclyde and St Andrews which will help developing countries to access battery technologies to drive green growth and give millions a ladder out of poverty.”
Nearly a tenth of the world’s population – 733 million people – do not have access to the electricity they need to light their homes, refrigerate their food, or keep cool in rising temperatures. Around 2.4 billion people rely on dirty biomass fuels such as charcoal, firewood, or animal waste for cooking.
The Foreign Secretary used his COP26 anniversary visit to witness the start of refurbishment work at the FCDO’s joint HQ in East Kilbride.
The Foreign Secretary was shown a research project led by the University of Strathclyde, which is developing a low-cost battery which is expected to last longer and be more easily recycled.
St Andrews demonstrated battery technology made from common salt, which could enable a move away from materials such as lithium and cobalt which are more expensive, rarer and harder on the environment to source.
Both technologies are expected to be ready to test this year.
Dandelion’s cubes are going on tour, starting on top of the iconic Calton Hill in Edinburgh. Special cargo bikes, featuring Dandelion’s unique ‘growing cubes’ called ‘Cubes of Perpetual Light’, will be touring Scotland in Dandelion’s latest initiative to bring music, nature, art, science, community food growing and more, to as many people as possible.
The Cubes Bike Tour forms part of Dandelion, a major creative programme demonstrating the power of collective action through an ambitious ‘grow your own’ initiative that aims to reach hundreds of thousands of people throughout Scotland and further afield this summer.
The creative programme has been following the arc of the growing season, spanning from April to September 2022, bringing together music and art with science and technology to inspire people to ‘Sow, Grow and Share’ music, food, ideas and stories.
Commissioned by EventScotland and funded by the Scottish Government, Dandelion is Scotland’s contribution to UNBOXED: Creativity in the UK.
A touring fleet of cargo bikes displaying Dandelion’s growing cubes – miniature vertical farms – will travel the Highlands and Lowlands throughout August.
Four custom-made, electrically assisted bikes – each carrying a cube – will visit ten towns and cities, stopping at school playgrounds, green spaces, town centres, and Dandelion’s Unexpected Gardens, among other locations.
The bikes team will also be giving away free seeds to encourage people to grow their own food. As we come to grips with the impacts of climate change, the need to travel sustainably have never been more important, and the cargo bikes show one way to what is possible.
The bikes also embed active travel at the core of the tour by cycling across the country, as Scotland prepares to host the UCI Cycling World Championships in 2023.
The 1m x 1m cubes are designed to foster accelerated plant growing and have been developed to grow hundreds of seedlings under LED light, combining design craft, traditional horticultural expertise and technological innovation.
The Dandelion team will also be giving away free seed packets and sharing their expertise, so that everyone can grow their own herbs at home and also find out more about Dandelion’s Harvest celebrations in September.
At each stop, the cubes will play new music specially commissioned for Dandelion by Scottish and international artists, inspired by the natural world and can only be heard at the sites, including Vendanth Bharadwaj, Arooj Aftab & Maeve Gilchrist, 2022 Mercury-nominated Fergus McCreadie, Ravi Bandhu, Trio Da Kali, and amiina & Kathleen MacInnes.
Featuring programmable, immersive lighting integrated with speaker systems designed to best showcase the new music playing from the cubes. Each new music piece is commissioned by Dandelion with additional support for international work from British Council Scotland.
Neil Butler, Director of Festivals and Events at Dandelion, said: ‘We can’t wait for the Cubes Bike Tour to begin. It’s a great way to share Dandelion’s message and reach people in locations throughout Scotland.
“The bikes will be travelling all over the country so we’d love to see people coming along to witness some of the magic, get seeds to grow your own at home and hear more about our upcoming Harvest celebrations.’
Paul Bush OBE, Visit Scotland Director of Events said:“The Dandelion programme is creating an incredible array of events across Scotland this summer, each finding unique moments to connect with people all over the country through growing.
“The Cubes Bike Tour is another engaging example of this, taking Dandelion right into the heart of locations right across Scotland to be enjoyed by locals and visitors alike.
“It’s also fantastic to see events like this embed active travel as part of their programme, and it’s particularly exciting to see biking at the core of this tour as Scotland gears up to celebrate cycling on the world-stage in one year’s time, hosting the 2023 UCI Cycling World Championships”.
Cosmo Blake, Network Engagement Manager at Sustrans Scotland “We are delighted to be able to support Dandelion by supplying four cargo bikes for the Cubes Bike Tour this August.
“By utilising the National Cycle Network, the UK-wide network of signed paths and routes for walking, wheeling and cycling, the tour will be able to reach communities sustainably. With the ever-present impacts from climate change, the importance of both food and transport sustainability are becoming more and more relevant.
“Bringing together active travel, growing, and the arts is a fantastic way to demonstrate the huge breadth of possibilities of cycling for transport as well as for leisure.”
The Cube Bikes will be passing through the places below:
Edinburgh, Tue 2 August
1pm, Edinburgh Botanic Gardens
4pm, Unexpected Garden, Lauriston Farm
Hawick, Wed 3 August
4pm, Hawick Museum, Wilton Lodge Gardens
Stranraer, Fri 5 August
1pm, Unexpected Garden, Harbour Street
Greenock, Sat 6 August
10.30am, Battery Park and along the esplanade
11.30am, Beacon Arts Centre
2pm, The Drying Green, Inverkip Road
Glasgow, Sun 7 August
10.00am, Govan Cross
12noon, Glasgow Science Centre
Forres, Tue 23 August
1pm, Market Square
7pm, Grant Park
Inverness, Wed 24 August
5.30pm, City Centre
Alness, Thu 25 August
Schools tour only
Wick, Fri 26 August
11am, Harbour tour
1pm, Market Square
Thurso, Sat 27 August
1pm, Town Centre
7.30pm, Unexpected Garden
Further locations to be announced throughout August.
For more information and location updates, please see: www.dandelion.scot
Dandelion is commissioned by EventScotland, funded by the Scottish Government and is part of UNBOXED: Creativity in the UK. The bikes were commissioned for Dandelion by Sustrans. The Cube Bikes Tour route will follow the National Cycle Network where available. https://www.sustrans.org.uk/national-cycle-network/
A mobile exhibit, highlighting the science and issues around air pollution and air quality, is on display in Edinburgh this summer.
The Scottish Environment Protection Agency (SEPA) and the Glasgow Science Centre launched the touring exhibition in 2020, aiming to highlight the importance of air quality. It will be on display until the end of August at Leith Library.
The interactive exhibit encourages visitors of all ages to think about their local environment and the quality of the air, how poor air quality can affect them and their family and how we can all help to improve air quality through our daily choices. The interactive exhibit also uses a bespoke tool which allows visitors to share their thoughts on the environments they live and work in, and what can be done to improve air quality.
The exhibit uses a simulation model to control traffic and allow users to experience how different types of transport contribute to air pollution. At the same time, the interactive display provides information on the various sources of air pollution and how it can affect our health and wellbeing.
Dr Colin Gillespie, SEPA’s Air Modelling Unit Manager, said: “Reducing air pollution and its associated health impacts is a challenge we should all be mindful of. We all contribute to sources of air pollution through our day-to-day activities and all breathe the same air, so we all have a part to play in improving air quality, no matter how small our actions may seem.
“This mobile exhibition highlights how individuals can take steps to help improve the quality of life both for ourselves and our wider communities and the simulation demonstrates the different ways the quality of the air we breathe can be impacted.”
Transport and Environment Convener at The City of Edinburgh Council, Councillor Scott Arthur, said: “This fascinating and engaging exhibition will really get people thinking about the impacts of poor air quality on our lives, and the choices we can make to limit this.
“Earlier this year I was proud to launch the Low Emission Zone in Edinburgh as this will reduce air pollution across the city. This is just one of a number of tools the Council is using to tackle poor air quality, from improvements to its vehicles to better infrastructure supporting cleaner modes of transport like walking and cycling, and for Leithers the Tram to Newhaven. What’s more, people using Lothian Buses can be reassured it has one of the cleanest fleets in the UK.
“Visiting this interactive exhibition at Leith Library will provide an insight into the need to make these kinds of changes for the good of all in our city.”
Dr Gillian Lang, Director of Experience Development at Glasgow Science Centre, said: “We are delighted to have been able to partner with SEPA on developing this touring exhibition to raise awareness of the science and issues around air quality.
“The exhibition was at Glasgow Science Centre during COP26 and has toured to Aberdeen Science Centre where it has been seen by over 16,000 people.”
The mobile exhibition is part of a larger educational package which SEPA has developed with Glasgow Science Centre, aiming to highlight the importance of air pollution and the impacts it can have on our health and the environment.
In 2017, SEPA and the Glasgow Science Centre developed a larger, permanent installation which was originally commissioned by the Scottish Government as part of the Cleaner Air for Scotland (CAFS) strategy, encouraging an interactive way to explore the science behind air pollution.
The mobile exhibit is a development of this work and is now available to tour individual local authority areas.
Anyone interested in finding out more information on how to bring the exhibit to their area can contact SEPA via AirQuality@sepa.org.uk.
The Scottish premiere of Doctor Who Worlds of Wonder will take place at the National Museum of Scotland in Edinburgh this December.
This ground-breaking new exhibition, which runs from 10 December 2022 to 1 May 2023, will explore the science behind the global hit television series Doctor Who and will give fans a chance to experience the Doctor’s adventures from a scientific perspective.
Produced by leading experiential design experts Sarner International under license from BBC Studios, this new exhibition invites fans of all ages to explore the role science has played in the world’s longest running action-adventure show. The eight zones set within this educational exhibition cover a diverse selection of exciting scientific topics while drawing in content from across the full canon of Doctor Who.
A range of hands-on immersive experiences and interactive features take visitors on a journey through Cosmic Curiosities, a TARDIS Tech room and the science behind time travel asking whether it really is possible, as well as the Monster Vault, where you can get up close with some of the weird and wonderful characters that have graced our screens.
Doctor Who Worlds of Wonder will offer a thrilling exploration of science for both established fans of the TV show and newcomers alike. The exhibition premiered at National Museums Liverpool’s World Museum, where it will run until 30 October.
Alison Cromarty, Head of Exhibitions & Design at National Museums Scotland, said: “We are tremendously excited to be bringing this exhibition to Scotland.
“From the wonder of the science fiction of the TV show to our present-day understanding of the big scientific topics it touches on, there is something for everyone.”
Ed Cookson, Projects Director, Sarner International: “For almost 60 years Doctor Who has been exploring mind-bending scientific developments.
“The iconic characters, monsters, stories, and settings of the television series provide a perfect guide through the wondrous worlds of space, time and science.”
Doctor Who has strong Scottish connections. To date three Scots have played the role of The Doctor, Sylvester McCoy, David Tennant and Peter Capaldi (the Seventh, Tenth and Twelfth Doctors respectively) with a fourth, Ncuti Gatwa, recently announced as the new Doctor.
Other notable cast members have included Companions Karen Gillan and Neve McIntosh as well as Michelle Gomez as Missy (The Master), with Alan Cumming having also appeared recently as King James VI & I.
Another Scot, Steven Moffat, was showrunner from 2008 to 2017.
The show has featured several other Scottish icons. The Loch Ness Monster appears in 1975’s Terror of the Zygons with Tom Baker, while the Picts featured along with the 9th Legion of the Roman army in 2017’s The Eaters of Light (which starred Peter Capaldi and Michelle Gomez).
Other episodes set in Scotland include 2006’s Tooth and Claw, set in the Highlands and Under the Lake/Before the Flood (2015), set in Caithness.
The National Museum of Scotland is supported by players of People’s Postcode Lottery in mounting the exhibition.
Tickets for Doctor Who World of Wonder will go on sale this autumn at:
